James Meek, MPH
Associate Director, Yale Emerging Infections Program, and Lecturer in Epidemiology (Microbial Diseases)DownloadHi-Res Photo
Cards
Additional Titles
Associate Director, Yale Emerging Infections Program
Contact Info
About
Copy Link
Titles
Associate Director, Yale Emerging Infections Program, and Lecturer in Epidemiology (Microbial Diseases)
Associate Director, Yale Emerging Infections Program
Biography
Mr. Meek is the associate director of the Yale office of the Connecticut Emerging Infections Program, a joint effort between the State of Connecticut Department of Public Health, the Yale School of Public Health Department of Epidemiology and Public Health (EPH), and the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. This CDC-funded program is one of twelve programs nationwide that seek to assess, through population-based surveillance, the public health impact of emerging infectious diseases and to evaluate methods for their prevention and control in the community.
In the EIP, Mr. Meek has overseen the establishment and maintenance of regional and statewide population-based surveillance systems for multiple emerging infections (foodborne disease, tickborne disease, liver disease, HPV disease, fungal disease, respiratory disease) and, based on surveillance findings, implemented research studies (case-control, cohort, vaccine effectiveness) to identify risk factors and evaluate prevention programs. The Yale office of the Connecticut EIP has provided training in surveillance and applied public health to over 300 MPH/doctoral students through internships, practicum experiences and thesis projects.
Last Updated on April 26, 2024.
Departments & Organizations
Education & Training
- MPH
- University of Connecticut (2000)
Research
Copy Link
Overview
Medical Research Interests
Epidemiology; Tick Control; Ticks; Zoonoses
Public Health Interests
Respiratory Disease/Infections; Antimicrobial Resistance; Emerging Infectious Diseases; Enteric Diseases
ORCID
0000-0001-5553-1675- View Lab Website
CT Emerging Infections Program
Research at a Glance
Yale Co-Authors
Frequent collaborators of James Meek's published research.
Publications Timeline
A big-picture view of James Meek's research output by year.
Research Interests
Research topics James Meek is interested in exploring.
Kimberly Yousey-Hindes, MPH
AmberJean P. Hansen, MPH, CCRP
David Banach, MD, MPH, MS
Monica Brackney, MS
Erol Fikrig, MD
Forrest W. Crawford, PhD
115Publications
7,214Citations
Tick Control
Ticks
Publications
2026
104. Association of Oseltamivir use with Clinical Outcomes of Children Hospitalized with Influenza — Influenza Hospitalization Surveillance Network, 2014-2023
Rytlewski K, Dunn A, O’Halloran A, Habeck J, Armistead I, Alden N, Kirley P, Meek J, Openo K, Ryan P, Kim S, Lynfield R, Shaw Y, Anderson B, Gaitan M, Lung K, Sutton M, Talbot H, Mendez-Edwards E, Cataldi J, Dominguez S, Bozio C, Rao S. 104. Association of Oseltamivir use with Clinical Outcomes of Children Hospitalized with Influenza — Influenza Hospitalization Surveillance Network, 2014-2023. Open Forum Infectious Diseases 2026, 13: ofaf695.039. PMCID: PMC12793175, DOI: 10.1093/ofid/ofaf695.039.Peer-Reviewed Original ResearchConceptsUnivariate Cox regression analysisIntensive care unitCox regression analysisInfluenza Hospitalization Surveillance NetworkLaboratory-confirmed influenza hospitalizationsLength of stayIntensive care unit admissionInfluenza vaccination statusHospital length of stayClinical outcomesOseltamivir treatmentCare unitConstitutional symptomsInfluenza hospitalizationsCox modelAntiviral treatmentHospital lengthICU admissionHazard ratioInfluenza A virus subtypesLow riskRisk of intensive care unitInfluenza-associated hospitalizationsSame-day treatmentInfluenza A subtypesP-544. Respiratory and Nonrespiratory Complications in Children Hospitalized with Influenza in the Post-2009 H1N1 Pandemic Era
Kamidani S, Witt L, Patterson A, Turner E, Fawcett E, Chai S, Armistead I, Meek J, Leegwater L, McMahon M, Martinez M, Rowlands J, Sutton M, Reyes I, Castagna-McLeod C, O’Halloran A, Bozio C, Openo K. P-544. Respiratory and Nonrespiratory Complications in Children Hospitalized with Influenza in the Post-2009 H1N1 Pandemic Era. Open Forum Infectious Diseases 2026, 13: ofaf695.759. PMCID: PMC12792649, DOI: 10.1093/ofid/ofaf695.759.Peer-Reviewed Original ResearchConceptsLaboratory-confirmed influenzaInfluenza Hospitalization Surveillance NetworkFluSurv-NETNonrespiratory complicationsIn-Hospital OutcomesAntiviral useNonrespiratory diagnosesCenters for Disease Control and Prevention Emerging Infections ProgramFrequency of severe outcomesHospitalized childrenRespiratory diagnosesInfluenza-associated complicationsInfluenza-related complicationsInfluenza B virusEmerging Infections ProgramAcute kidney injuryAcute diagnosisDiagnosis categoriesCharacteristics of patientsPopulation-based studySurveillance networkInternational ClassificationBavarian NordicInfluenza seasonInfluenza types
2025
Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2020–2023
Hamid S, Derado G, Pham H, Woodruff R, Melgar M, Roland J, Kawasaki B, Meek J, Witt L, Monroe M, Reeg L, Martin E, Akpo J, Barney G, Felsen C, Moran N, Sutton M, Talbot H, Swain A, Havers F, Taylor C. Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2020–2023. American Journal Of Preventive Medicine 2025, 70: 108227. PMID: 41423029, DOI: 10.1016/j.amepre.2025.108227.Peer-Reviewed Original ResearchAltmetricConceptsRisk of COVID-19 hospitalizationChronic conditionsCOVID-19 hospitalizationCOVID-19 hospitalization ratesHospitalization ratesBehavioral Risk Factor Surveillance SystemRisk Factor Surveillance SystemRisk factorsAdjusted rate ratiosCross-sectional survey dataStronger risk factorChronic obstructive pulmonary diseaseU.S. Census dataObstructive pulmonary diseaseCOVID-19-Associated Hospitalization Surveillance NetworkPoisson regressionRate ratiosCOVID-19-associated hospitalizationCoronary artery diseaseChronic kidney diseaseCOVID-19-associatedAdult populationHospitalization countsSurveillance systemHospitalized adultsHospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022-2024.
Free R, Patel K, Taylor C, Sachdev D, Kawasaki B, Meek J, Openo K, Ryan P, Reeg L, D'Heilly P, Smelser C, Engesser K, Tesini B, Sutton M, Keipp Talbot H, Swain A, Campbell A, Havers F. Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022-2024. 2025, 156 PMID: 40604359, DOI: 10.1542/peds.2025-072788.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHospitalized children aged 6Children Aged 6COVID-19-Associated Hospitalization Surveillance NetworkSevere diseaseAged 6Risk factorsAssociated with chronic lung diseaseCOVID-19 vaccineCOVID-19 hospitalizationLaboratory-confirmed SARS-CoV-2 infectionPoisson generalized estimating equationsChronic lung diseaseSARS-CoV-2 infectionChildren Aged 2High-risk conditionsRisk of severe illnessClinical outcomesChronic lungAges 2 to 4Lung diseaseCardiovascular diseaseCOVID-19Severe outcomesSevere illnessMedical conditions427. Underlying Medical Conditions and Vaccination Status among U.S. Children Aged ≤17 Years Hospitalized for COVID-19 in COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), January–December 2023
Free R, Patel K, Sachdev D, Alden N, Meek J, Ryan P, Falkowski A, D’Heilly P, Smelser C, Engesser K, Bushey S, Moran N, Sutton M, Talbot H, Swain A, Campbell A, Havers F, Openo K. 427. Underlying Medical Conditions and Vaccination Status among U.S. Children Aged ≤17 Years Hospitalized for COVID-19 in COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), January–December 2023. Open Forum Infectious Diseases 2025, 12: ofae631.141. PMCID: PMC11777352, DOI: 10.1093/ofid/ofae631.141.Peer-Reviewed Original ResearchConceptsCOVID-19-Associated Hospitalization Surveillance NetworkAge-eligible childrenChildren Aged 6Medical conditionsCOVID-19 hospitalizationVaccine doseAcute care hospitalsAged 6Random sample of childrenPositive SARS-CoV-2 test resultSARS-CoV-2 test resultsVaccination statusAssessed patient ageSample of childrenNeurological disordersMaster of ScienceSARS-CoV-2 infectionActive surveillance systemCare hospitalProbability of selectionPediatric COVID-19 vaccineCOVID-19U.S. childrenPatient ageMedical recordsP-2008. Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2022-2023
Hamid S, Derado G, Pham H, Woodruff R, Sachdev D, Kawasaki B, Meek J, Witt L, Ryan P, Kim S, Bye E, Akpo J, Rowlands J, Licherdell E, Shiltz E, Sutton M, Talbot K, Price A, Havers F, Taylor C. P-2008. Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2022-2023. Open Forum Infectious Diseases 2025, 12: ofae631.2165. PMCID: PMC11777768, DOI: 10.1093/ofid/ofae631.2165.Peer-Reviewed Original ResearchAltmetricConceptsChronic conditionsHospitalization ratesRisk factorsBehavioral Risk Factor Surveillance SystemRate ratiosRisk Factor Surveillance SystemPopulation-based active surveillance systemCOVID-19-associated hospitalizationSurveillance systemCounty-level population dataOlder ageAge groupsAssociated with increased riskHistory of strokeCouncil of StateCOVID-19-Associated Hospitalization Surveillance NetworkPoisson regressionRate denominatorCatchment areaActive surveillance systemAnalytic populationConfidence intervalsAdult populationHospitalization countsHospitalized adults
2024
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach
Devine O, Pham H, Gunnels B, Reese H, Steele M, Couture A, Iuliano D, Sachdev D, Alden N, Meek J, Witt L, Ryan P, Reeg L, Lynfield R, Ropp S, Barney G, Tesini B, Shiltz E, Sutton M, Talbot H, Reyes I, Havers F. Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach. Influenza And Other Respiratory Viruses 2024, 18: e70026. PMID: 39440677, PMCID: PMC11497105, DOI: 10.1111/irv.70026.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsBarriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017
Hansen A, Wilkinson M, Niesobecki S, Rutz H, Meek J, Niccolai L, Hinckley A, Hook S. Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017. Journal Of Public Health Management And Practice 2024, 31: e52-e60. PMID: 39321400, DOI: 10.1097/phh.0000000000002033.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPersonal safety concernsPreventive measuresBarriers to consistent usePublic health programsLogistic regression modelsHealth programsTickborne diseasesDisease prevention measuresDemographic variablesPrimary barrierOutdoor activitiesTick checksDescriptive analysisOnline surveyRegression modelsSafety concernsCost concernsNatural pesticidesIncreased uptakePreventionBarriersTick habitatsSurveyConnecticutConcernsAn evaluation of outcomes and hospital readmissions among individuals with candidemia using statewide surveillance
Suschana E, Correa M, Meek J, Banach D. An evaluation of outcomes and hospital readmissions among individuals with candidemia using statewide surveillance. Infection Control And Hospital Epidemiology 2024, 45: 998-1002. PMID: 38561197, DOI: 10.1017/ice.2024.52.Peer-Reviewed Original ResearchCitationsAltmetricCharacteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, Johnston H, Basiliere E, Meek J, Olson D, Fridkin S, Wilson L, Perlmutter R, Holzbauer S, D’Heilly P, Phipps E, Flores K, Dumyati G, Pierce R, Ocampo V, Wilson C, Watkins J, Gerding D, McDonald L. Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences. Open Forum Infectious Diseases 2024, 11: ofae127. PMID: 38577028, PMCID: PMC10993058, DOI: 10.1093/ofid/ofae127.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRecurrent Clostridioides difficile infectionClostridioides difficile infectionInitial CDINitrofurantoin useMultiple recurrent Clostridioides difficile infectionsPositive testPositive C. difficile testMultiple CDI recurrencesMultivariate logistic regression analysisPrevent further recurrenceAssociated with increased riskIntervention study designProportion of patientsTime of presentationCharacteristics of patientsLogistic regression analysisClinical decision makingCDI recurrenceChronic hemodialysisAdjunctive therapyIncreased riskMultivariate analysisStudy designPatientsClinical setting
Academic Achievements & Community Involvement
Copy Link
News
Copy Link
News
- May 18, 2020Source: STAT News
Life as a Covid-19 contact tracer: sleuthing, stress, and veering off-script
- March 11, 2020Source: CT Mirror
With coronavirus spreading in Connecticut, when is it appropriate to close schools?
- May 02, 2013
Foodborne Illnesses
- December 15, 2011
Statins May Reduce Mortality in Influenza Patients
Get In Touch
Copy Link
Contacts
Locations
Yale Emerging Infections Program
Academic Office
1 Church Street, Ste 7th Floor
New Haven, CT 06510
Fax
203.764.4357Appointments
203.737.6339